RAPT Therapeutics rapt.com


Public list: Smart Money VCs (6326) Pharma Startups (6570) Cancer Therapeutics (1180) Google In Healthcare (60)

RAPT Therapeutics (NASDAQ: RAPT) is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Utilizing its proprietary drug discovery and development engine, the company develops highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases.

RAPT Therapeutics (NASDAQ: RAPT) is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. ...Show all

Company (IPO / Went public)

All investors data 6 Investors

Phone: 650-489-9000

Fax:

561 Eccles Avenue

 South San Francisco, 94080
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
RAPT Therapeutics $147M Oct 31, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related RAPT Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

Name Firm
Login to see detailsThe Column Group
Login to see detailsHealthSpring
Login to see detailsWestlake Village BioPartners
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereof Nov 13, 2018 Jul 28, 2020 Patent
Chemokine receptor modulators and uses thereof Jan 24, 2019 Jun 16, 2020 Patent
Chemokine receptor modulators and uses thereof Nov 19, 2018 Mar 31, 2020 Patent
Chemokine receptor modulators and uses thereof Sep 08, 2017 Apr 02, 2019 Patent
Chemokine receptor modulators and uses thereof Jul 28, 2017 Jan 15, 2019 Patent
See all 11 patents